CNOT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.868400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.662780E-01
Normal-vs-Stage2
6.377000E-01
Normal-vs-Stage3
5.574000E-02
Normal-vs-Stage4
3.508800E-01
Stage1-vs-Stage2
5.726800E-01
Stage1-vs-Stage3
2.976400E-02
Stage1-vs-Stage4
7.962000E-01
Stage2-vs-Stage3
4.868400E-01
Stage2-vs-Stage4
9.747800E-01
Stage3-vs-Stage4
1.856020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.383030E-01
Normal-vs-AfricanAmerican
2.137000E-01
Normal-vs-Asian
6.123000E-01
Caucasian-vs-AfricanAmerican
9.167600E-01
Caucasian-vs-Asian
4.034800E-01
AfricanAmerican-vs-Asian
4.168400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.538200E-01
Normal-vs-Female
9.961800E-02
Male-vs-Female
2.280600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.775420E-01
Normal-vs-Age(41-60Yrs)
9.666400E-01
Normal-vs-Age(61-80Yrs)
1.006980E-01
Normal-vs-Age(81-100Yrs)
1.150600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.581200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.345800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.864800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.665600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.230780E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.119800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.730400E-02
Normal-vs-Daily Drinker
1.843790E-02
Normal-vs-Weekly Drinker
2.276000E-02
Normal-vs-Occasional Drinker
5.573000E-01
Normal-vs-Social Drinker
3.849800E-02
Non Drinker-vs-Daily Drinker
8.053600E-01
Non Drinker-vs-Weekly Drinker
7.577800E-01
Non Drinker-vs-Occasional Drinker
1.644210E-01
Non Drinker-vs-Social Drinker
1.434830E-01
Daily Drinker-vs-Weekly Drinker
6.108000E-01
Daily Drinker-vs-Occasional Drinker
1.752590E-01
Daily Drinker-vs-Social Drinker
2.087200E-01
Weekly Drinker-vs-Occasional Drinker
1.519620E-01
Weekly Drinker-vs-Social Drinker
1.130600E-01
Occasional Drinker-vs-Social Drinker
2.418800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.520500E-02
Normal-vs-Grade 2
3.539600E-01
Normal-vs-Grade 3
1.978390E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.335000E-01
Grade 1-vs-Grade 3
8.489000E-01
Grade 1-vs-Grade 4
5.520500E-02
Grade 2-vs-Grade 3
4.714600E-01
Grade 2-vs-Grade 4
3.539600E-01
Grade 3-vs-Grade 4
1.978390E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.082410E-01
Normal-vs-NonDiabetic
6.686200E-01
Diabetic-vs-NonDiabetic
2.799600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.189740E-02
Normal-vs-NoPancreatitis
6.333200E-01
Pancreatitis-vs-NoPancreatitis
1.603980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.996400E-02
Normal-vs-N1
1.680840E-01
N0-vs-N1
8.928400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.648200E-01
Normal-vs-TP53-NonMutant
2.616000E-01
TP53-Mutant-vs-TP53-NonMutant
1.887810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
